|
Volumn 111, Issue 4, 2008, Pages 2488-2489
|
Significance of PRDM1β expression as a prognostic marker in diffuse large B-cell lymphomas
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MESSENGER RNA;
RITUXIMAB;
ANTINEOPLASTIC AGENT;
PRDM1 PROTEIN, HUMAN;
REPRESSOR PROTEIN;
TRANSCRIPTION FACTOR;
B CELL LYMPHOMA;
CELL LINE;
CHEMOTHERAPY;
CORRELATION ANALYSIS;
GENE;
GENE EXPRESSION;
GENETIC TRANSCRIPTION;
HUMAN;
HUMAN CELL;
LARGE CELL LYMPHOMA;
LETTER;
PRDM1ALPHA GENE;
PRDM1BETA GENE;
PRIORITY JOURNAL;
PROGNOSIS;
QUANTITATIVE ANALYSIS;
REAL TIME POLYMERASE CHAIN REACTION;
SURVIVAL;
WESTERN BLOTTING;
GENETICS;
NOTE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
HUMANS;
LYMPHOMA, B-CELL;
LYMPHOMA, LARGE B-CELL, DIFFUSE;
PROGNOSIS;
REPRESSOR PROTEINS;
TRANSCRIPTION FACTORS;
|
EID: 41349093781
PISSN: 00064971
EISSN: 00064971
Source Type: Journal
DOI: 10.1182/blood-2007-09-111385 Document Type: Letter |
Times cited : (7)
|
References (6)
|